ABEONA THERAPEUTICS INC. Other Loans Payable, Current
ABEONA THERAPEUTICS INC. (ABEO) had Other Loans Payable, Current of $4.69 million as of 2024-03-31, per its 10-Q filed 2024-05-15.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Long-Term Debt, Current Maturities
us-gaap:OtherLoansPayableCurrent · last filed 2025-03-20
- 2024-03-31: Other Loans Payable, Current $4.69M.
- 2023-12-31: Other Loans Payable, Current $4.58M.
| Period end | Other Loans Payable, Current |
|---|---|
| 2024-03-31 | $4.69M 10-Q · filed 2024-05-15 |
| 2023-12-31 | $4.58M 10-K · filed 2025-03-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |